A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Clinical trial NCT06372821 · RECRUITING

Trial details

NCT number: NCT06372821
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder)

Start date: 2024-11-18
Primary completion: 2026-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.